Clinical trial

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation

NCT05138029

Study summary

ClinicalTrials.gov

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Ranibizumab Injection [Lucentis] Normalized identity: ranibizumab Injection [Lucentis] View linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Inner limiting membrane stripping Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Dexamethasone intravitreal implant Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-11-15

PhasePHASE3

Conditions

Diabetic Retinopathyverified · MONDO: diabetic retinopathy

Interventions

Ranibizumab Injection [Lucentis]DRUG · verified · RxNorm: ranibizumab Injection [Lucentis]

Inner limiting membrane strippingPROCEDURE

Dexamethasone intravitreal implantDRUG

Sponsors & collaborators

Affiliated Hospital of Nantong Universitylead sponsor

Mapped research locations

NantongJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05138029 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.